
Xolinib®
Sorafenib
Therapeutic action
Antineoplastic
Indications
Renal cell carcinoma / Inoperable hepatocellular carcinoma / Differentiated thyroid carcinoma
Presentation
Coated tablets of 200 mg
Antineoplastic
Renal cell carcinoma / Inoperable hepatocellular carcinoma / Differentiated thyroid carcinoma